<DOC>
	<DOCNO>NCT00897299</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict whether cancer come back treatment . PURPOSE : This laboratory study identify gene may help predict recurrence woman breast cancer treat chemotherapy .</brief_summary>
	<brief_title>Identifying Genes That Predict Recurrence Women With Breast Cancer Treated With Chemotherapy</brief_title>
	<detailed_description>OBJECTIVES : - Assess prognostic utility Oncotype DXâ„¢ 21 gene profile risk relapse woman node positive high-risk node negative breast cancer . - Identify individual gene whose RNA expression associate increase risk relapse patient . - Perform exploratory analysis individual gene whose RNA expression associate increase risk relapse differentially patient previously treat docetaxel . OUTLINE : This multicenter study . Tissue sample examine association RNA expression clinical factor ( e.g. , tumor size , nodal status , hormone receptor status , age , menopause status ) , well estrogen receptor , progesterone receptor , HER-2/neu expression immunohistochemistry study . PROJECTED ACCRUAL : A total 900 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis breast cancer Node positive OR highrisk node negative disease Tumor &gt; 1.0 cm diameter No locally advance , inflammatory , metastatic breast cancer Previously treat 4 course anthracyclinecontaining chemotherapy ( i.e. , doxorubicin docetaxel OR doxorubicin cyclophosphamide ) Enrolled clinical trial ECOGE2197 Adequate tumor material available ECOG Pathology Coordination Center Previously consent future cancerrelated research Hormone receptor status know PATIENT CHARACTERISTICS : Female Menopausal status specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>estrogen receptor</keyword>
	<keyword>HER-2</keyword>
	<keyword>PgR</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
</DOC>